QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 发表日期：2016    专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis 期刊论文 DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 卷号: 10, 页码: 1961-1972 作者:  Wang, Yuan;  Hu, Guo-fang;  Zhang, Qian-qian;  Tang, Ning;  Guo, Jun 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/16 advanced pancreatic cancer  chemotherapy  targeted agent  meta-analysis   Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer A retrospective, STROBE-compliant study 期刊论文 MEDICINE, 2016, 卷号: 95, 期号: 51 作者:  Wang, Fei;  Du, Xuelian;  Li, Xiaoxia;  Liu, Naifu;  Yu, Hao 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/16 carboplatin  epithelial ovarian cancer  gemcitabine  paclitaxel  sequential chemotherapy   miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer 期刊论文 ONCOLOGY REPORTS, 2016, 卷号: 35, 期号: 3, 页码: 1365-1374 作者:  Ren, Zhi-Guo;  Dong, Shu-Xiao;  Han, Ping;  Qi, Jian 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/16 SIK1  miR-203  gemcitabine resistance  pancreatic cancer   Effects of sequential paclitaxel–carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study 期刊论文 Medicine, 2016, 期号: 51, 页码: e5696-e5696 作者:  Fei.Wang;  Xuelian.Du;  Xiaoxia.Li;  Naifu.Liu;  Hao.Yu 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated 期刊论文 TUMOR BIOLOGY, 2016, 卷号: 37, 期号: 9, 页码: 12731-12742 作者:  Yin, Lei;  Liu, Shuai;  Li, Chensheng;  Ding, Sentai;  Bi, Dongbin 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/16 Gemcitabine  Cylindromatosis (CYLD)  Livin  Bladder cancer (BCa)  Autophagy   Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo 期刊论文 ONCOLOGY REPORTS, 2016, 卷号: 36, 期号: 6, 页码: 3488-3496 作者:  Zhu, Hua-Qiang;  Ma, Jin-Ben;  Song, Xie;  Gao, Heng-Jun;  Ma, Chao-Qun 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 cholangiocarcinoma  metformin  gemcitabine  cisplatin   Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer 期刊论文 INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 卷号: 513, 期号: 1-2, 页码: 564-571 作者:  Liang, Tie-Jun;  Zhou, Zhong-Mei;  Cao, Ying-Qing;  Ma, Ming-Ze;  Wang, Xiao-Jun 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/16 Gemcitabine  Polylactide  Polymer-drug conjugates  Anticancer efficacy  Apoptosis   Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients 期刊论文 CANCER RADIOTHERAPIE, 2016, 卷号: 20, 期号: 3, 页码: 181-186 作者:  Wang, T.;  Zhang, S. -F.;  Qiu, M-Q;  Li, Q. -L. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/16 S-1  Squamous cell lung carcinoma  3D-CRT  Gemcitabine   Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 卷号: 24, 期号: 22, 页码: 5787-5795 作者:  Jiang, Yuqi;  Hou, Jinning;  Li, Xiaoyang;  Huang, Yongxue;  Wang, Xuejian 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 CD13 inhibitor  Ubenimex  Gemcitabine (GEM)  Anti-angiogenesis  Anticancer   Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy 期刊论文 ONCOLOGY RESEARCH, 2016, 卷号: 24, 期号: 2, 页码: 129-135 作者:  Wang, Yue-shen;  Tian, Jing;  Han, Yong;  Han, Shu-mei;  Shi, Sheng-bin 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/16 Advanced esophageal cancer  Second-line treatment  Gemcitabine plus  vinorelbine  Platinum-based chemotherapy  miRNA-214  Progression-free  survival